Mahmoud S Abdallah
Overview
Explore the profile of Mahmoud S Abdallah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Samman W, Mosalam E, Saif D, Abdallah M, Zidan A, Sallam A, et al.
Front Pharmacol
. 2025 Mar;
16:1507693.
PMID: 40070566
Introduction: Understanding the molecular mechanism underlying the pathogenesis of knee osteoarthritis (KOA) may be beneficial in fetching new therapeutics. Our study aims to investigate the implication of Wnt/ β-catenin pathway...
2.
Binsaleh A, Abdallah M, Osman B, Bahaa M, Alsubaie N, Elmasry T, et al.
Antibiotics (Basel)
. 2025 Jan;
13(12.
PMID: 39766535
Antimicrobial resistance (AMR) has been identified as one of the top ten public health threats facing humanity. The purpose of this study was to assess the effect of an antimicrobial...
3.
Alarfaj S, Bahaa M, Elmasry T, Elberri E, El-Khateeb E, Hamouda A, et al.
Drug Des Devel Ther
. 2024 Nov;
18:5239-5253.
PMID: 39575188
Background: Ulcerative colitis (UC) is an idiopathic chronic inflammation of colonic and rectal mucosa. The peroxisome proliferator-activated receptor α (PPARα) has been identified as having protective effects in UC. Aim:...
4.
Sabit H, Abdel-Ghany S, Abdallah M, Abul-Maaty O, Khoder A, Shoman N, et al.
Inflammopharmacology
. 2024 Oct;
32(6):3631-3652.
PMID: 39406981
As of the 7 of July 2024, 775,754,322 confirmed cases of COVID-19, including 7,053,902 deaths worldwide, had been reported to the WHO (World Health Organization). Nevertheless, untill the 15 of...
5.
Aldossary K, Ali L, Abdallah M, Bahaa M, Elmasry T, Elberri E, et al.
Front Pharmacol
. 2024 Sep;
15:1464358.
PMID: 39268472
[This corrects the article DOI: 10.3389/fphar.2024.1381523.].
6.
Badawoud A, Ali L, Abdallah M, El Sabaa R, Bahaa M, Elmasry T, et al.
Front Pharmacol
. 2024 Aug;
15:1434512.
PMID: 39156113
Parkinson's disease (PD) is a neurological condition that typically shows up with aging. It is characterized by generalized slowness of movement, resting tremor or stiffness, and bradykinesia. PD patients' brains...
7.
Mosalam E, Elberri A, Abdallah M, Abdel-Bar H, Zidan A, Batakoushy H, et al.
Int J Mol Sci
. 2024 Jul;
25(14).
PMID: 39063042
Alzheimer's disease (AD) is a neurodegenerative disease that badly impacts patients and their caregivers. AD is characterized by deposition of amyloid beta (Aβ) and phosphorylated tau protein (pTau) in the...
8.
Mosalam E, Abdel-Bar H, Elberri A, Abdallah M, Zidan A, Batakoushy H, et al.
Int J Biol Macromol
. 2024 Jul;
275(Pt 2):133742.
PMID: 38986998
This study aims to investigate the molecular mechanisms and the neuroprotective effect of hyaluronic acid modified verapamil-loaded carbon quantum dots (VRH-loaded HA-CQDs) against an in-vitro Alzheimer's disease model induced by...
9.
Aldossary K, Ali L, Abdallah M, Bahaa M, Elmasry T, Elberri E, et al.
Front Pharmacol
. 2024 Jun;
15:1381523.
PMID: 38855751
Background: Neuroinflammation pathways have been associated with the development of major depressive disorders (MDD). The anti-inflammatory characteristics of statins have been demonstrated to have significance in the pathophysiology of depression....
10.
Kamal N, Abdallah M, Abdel Wahed E, Sabri N, Fahmy S
Pharmaceuticals (Basel)
. 2024 May;
17(5).
PMID: 38794179
Neurological injury is a crucial problem that interferes with the therapeutic use of vinca alkaloids as well as the quality of patient life. This study was conducted to assess the...